Consolidated Profit & Loss Statement (thousand TRY) | 2022 | 2023 |
Revenue | 25.944.510 | 42,245,216 |
Revenue From Finance Sector Operations | 3,661,493 | 10,320,232 |
Cost of Sales (-) | -21.762.546 | -34.349.594 |
Cost of Finance Sector Operations (-) | -2.930.842 | -8.632.055 |
Gross Profit/(Loss) (Non-Finance) | 4,181,963 | 7,895,622 |
Gross Profit/(Loss) (Finance) | 730,651 | 1,688,177 |
Gross Profit (Loss) | 4,912,615 | 9,583,799 |
Research and Development Expenses (-) | 119,933 | 238,803 |
General Administrative Expenses (-) | 1,556,281 | 2,146,945 |
Marketing Expenses (-) | 1,876,907 | 2,947,658 |
Other Income From Operating Activities | 4.799.181 | 7.127.597 |
Other Expenses From Operating Activities (-) | -1,069,659 | -668,778 |
Share of Gain (Loss) on Investments Accounted for by the Equity Method | 369,032 | 795,647 |
Operating Profit/(Loss) | 5,458,048 | 11,504,859 |
Income from Investment Activities | 3,777,108 | 7,919,978 |
Expenses from Investment Activities (-) | 543,072 | 195,821 |
Operating Profit (Loss) Before Finance (Expense)/Income | 8,692,084 | 19,229,016 |
Finance Income | 875,474 | 123,098 |
Finance Expenses (-) | -4,393,360 | -4,654,376 |
Monetary Gain/(Loss), net | -5,462,676 | -12,467,874 |
Profit (Loss) Before Taxation From Continued Operations | -288,478 | 2,229,864 |
Tax Income/(Expense) From Continued Operations | -539,659 | -1,478,942 |
Tax Income/(Expense) for the Period | -919,792 | -1,773,786 |
Deferred Tax Income/(Expense) | 380,133 | 294,844 |
Profit/(Loss) For The Period From Continued Operations | -828.137 | 750.922 |
Profit/(Loss) For The Period From Discontinued Operations | 2,121,783 | -734,805 |
Profit/(Loss) For The Period | 1,293,646 | 16,117 |
Allocation of Profit/(Loss) For The Period | ||
Attributable to Non-Controlling Interests | 1,061,531 | -280,477 |
Attributable to Equity Holders of the Parent Company | 232,115 | 296,594 |
Gain/(Loss) Per Share Attributable to Equity Holders of the Parent Company | 0,0896 | 0,1145 |